Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2013-10-18T18:15:09Z No. of bitstreams: 1 Murilo F. Castro. Avaliação da atividade,,, 2012.pdf: 1468986 bytes, checksum: 7b9241cb49aba27e80628022c24eb12a (MD5) / Made available in DSpace on 2013-10-18T18:15:09Z (GMT). No. of bitstreams: 1 Murilo F. Castro. Avaliação da atividade,,, 2012.pdf: 1468986 bytes, checksum: 7b9241cb49aba27e80628022c24eb12a (MD5) Previous issue date: 2012 / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / A doença de Chagas (DC) é considerada um agravo ainda negligenciado. Atualmente, estima-se cerca de 10 milhões de pessoas infectadas pelo Trypanosoma cruzi, em todo o mundo, principalmente na América Latina. Sabe-se que alguns derivados de naftoquinonas podem agir sobre a tripanotiona redutase (TR), enzima específica dos tripanossomatídeos responsável pelo controle oxidativo celular. A inibição da TR favorece um processo oxidativo e morte do protozoário. Este trabalho teve como objetivo investigar o potencial anti-T.cruzi da fitomenadiona, (K1) e menadiona (K3), ambas vitaminas K derivadas de naftoquinonas. Com este propósito, o efeito tripanocida de K1 e K3 foi avaliado através de ensaios in vitro com as formas tripomastigotas e epimastigotas do T. cruzi nas cepas Colombiana e Y utilizando os testes de inibição, citotoxicidade dos compostos, ensaio de infecção em macrófagos, avaliação de alterações ultraestruturais, bem como ensaio em in vivo para avaliação na redução da parasitemia. Os valores de IC50 mais significativos para formas tripomastigotas do T. cruzi foram 27,55 μM para K1, 2,19 μM para K3 e 12,46 μM para o benzonidazol, a droga padrão. Contudo, o tratamento com a vitamina K1 não reduziu a parasitemia in vivo, que permaneceu alta assim como a do controle tratado com veículo. A vitamina K3 foi capaz de inibir ambas as cepas e diferentes formas do parasito em ensaios in vitro. No ensaio de infecção de macrófagos, a vitamina K3 em concentração de 21,4 μM inibiu de forma mais significativa a infecção de células em relação à droga padrão, em concentração de 38,4 μM. Apesar da citotoxicidade mais elevada, esta droga apresentou uma seletividade maior ao parasito do que a células de mamíferos e, em baixas doses, causou a redução na parasitemia in vivo. As avaliações ultraestruturais por microscopia eletrônica de transmissão evidenciaram alterações celulares induzidas por estes compostos, destacando-se a tumefação do cinetoplasto e a presença de vacúolos. A quantificação ultraestrutural na avaliação por microscopia eletrônica de varredura demonstrou alterações em cerca de 80% dos parasitos observados quando tratados com K3 a 5 μM. Nossos resultados demonstram o efeito anti-T. cruzi das moléculas testadas e sugerem que estas possam servir de base para o desenho de novos compostos candidatos a fármacos para o tratamento da doença de Chagas. / Chagas disease (AD) is considered a neglected disease. Currently, it is estimated 10 million people infected with Trypanosoma cruzi, worldwide, mostly in Latin America. It is known that some derivatives of naphthoquinones can act on the trypanothione reductase (TR), specific enzyme of trypanosomatids responsible for controlling oxidative stress. Inhibition of TR favors an oxidative process and death of the parasite. This work aimed to investigate the potential anti-T. cruzi of phytomenadione, (K1) and menadione (K3), both vitamin K derived from naphthoquinones. For this purpose, the trypanocidal effect of K1 and K3 was evaluated by in vitro assays with epimastigotes and trypomastigotes of T. cruzi in strains Colombian and Y using the inhibition tests, cytotoxicity of compounds of infection in macrophages test, evaluation of ultrastructural alterations as well as in vivo test to evaluate the reduction of the parasitemia. The best IC50 values to trypomastigote forms of T. cruzi were 27.55 μM to K1 and 2.19 μM to K3, compared to 12.46 μM of benznidazole, the standard drug. However, the treatment with vitamin K1 did not reduce parasitemia in vivo, which remains high similar to the vehicletreated control group. Vitamin K3 was able to inhibit both strains and different forms of the parasite in in vitro assays. In macrophage infection assay, vitamin K3 at a concentration of 21.4 μM significantly inhibited T. cruzi infection of cells when compared to the standard drug (benznidazole) in a concentration of 38.4 μM. Although this compound had a high cytotoxicity, vitamin K3 showed greater selectivity than the parasite mammalian cells, and in a low dose caused a reduction in parasitemia in vivo. The ultrastructural evaluation by transmission electron microscopy revealed cellular alterations induced by these compounds, especially the swelling of the kinetoplast and the presence of vacuoles. The ultrastructural quantification in the evaluation by scanning electron microscopy showed changes in about 80% of parasites observed when treated with 5 μM K3. Our results demonstrate the anti-T. cruzi molecules tested, suggesting that they may serve as a basis for designing new drug candidate compounds for the treatment of Chagas disease.

TB is still one of the world's biggest killers. Immunosuppresion induced by AIDS caused a rise in the incidence of TB during the past decade. The search for new drugs to effectively treat TB remains one of the big challenges facing the scientific community. Drugs from plants have been used for centuries to treat various human diseases with varying degrees of success. South Africa with its big resource of plants and ethnobotanical knowledge is an ideal place to screen for anti- TB compounds. The Zulu tribe of South Africa used the root bark of Euclea nata/ensis A.DC. to treat TB related symptoms. Naphthoquinones isolated from E. nata/ensis proved to have good activity against TB. Nine compounds were isolated from the chloroform extract of E. nata/ensis root material. Three of these compounds were newly isolated from this species (mamegakinone, neodiospyrin and 5-hydroxy-4-methoxy-2-napthaldehyde). The structures of the isolated compounds were confirmed using NMR methods and where possible the HPLC and TLC results were compared to authentic standards. Most of the compounds were tested for anti- TB activity with only mamegakinone, lupeol and betulin not showing any activity (5-hydroxy-4-methoxy-2-napthaldehyde still needs to be tested). The activity of the naphthoquinones, especially 7-methyljuglone, diospyrin, isodiospyrin and neodiospyrin, show promise that these compounds could develop into an affordable medicine to treat TB. The activity of the crude extract against the resistant DP48 110 1 TB strain showed that there are probably unknown active compounds remaining in the extract. The most active compound, 7 -methyljuglone, was synthesised and an improved synthetic pathway was developed. The synthesis of naphthoquinones remains important in order to produce the compounds on a larger scale. This will make further studies into the mode of action, biosynthesis, bioactivity etc. of these compounds possible. Attempts were made to synthesise diospyrin with 7 -methyljuglone as the starting material. These experiments failed up to now. By altering the reaction parameters such as pH and temperature it should be possible to synthesise diospyrin in future attempts. Neodiospyrin were synthesised from reduced 7 -methyljuglone. This synthesis will yield information on the naphthoquinone chemistry and on how to synthesise diospyrin and isodiospyrin. The enzymatic synthesis of naphthoquinones was also investigated with the use of a cell-free extract. These experiments indicated that it might be possible to enzymatically synthesise diospyrin and the other dimers. / Dissertation (MSc (Plant Physiology))--University of Pretoria, 2005. / Plant Science / unrestricted

Breast cancer is a leading cause of cancer death in Africa. Hsp90 has been identified as a target for anti-cancer treatments as its inhibition results in the disruption and ubiquitin–proteasome degradation of activated oncoproteins. Currently, there are no US Food and Drug Administration approved Hsp90 inhibitor drugs and existing Hsp90 inhibitors such as geldanamycin and novobiocin are hepatotoxic and display a low affinity for Hsp90, respectively. Therefore, there is a need for the development of Hsp90 inhibitors with improved inhibitory properties. In this study twelve natural compounds bearing a quinone nucleus were screened and characterised for the modulation of Hsp90. The compounds analysed formed three series; the sargaquinoic acid (SQA), naphthoquinone, and pyrroloiminoquinone alkaloid series. Certain compounds exhibited half maximal inhibitory concentrations of between 3.32 μM and 12.4 μM, while others showed no antiproliferative activity at concentrations of up to 500 μM in the MDA-MB-231 breast adenocarcinoma cell line. Immunofluorescence and Western analyses indicated that the modulation of Hsp90 and partner proteins by SQA was more similar to that of novobiocin. Isothermal titration calorimetry analyses suggested that SQA interacted with Hsp90β with a low affinity, and saturation-transfer difference nuclear magnetic resonance confirmed that this interaction with Hsp90β occurred through the methyl moiety bound to 1, 4 benzoquinone of SQA. Pulldown assays indicated SQA disrupted the association between Hsp90 and Hop dose-dependently, more similarly to novobiocin. Immunofluorescence and Western analyses performed on naphthoquinone and pyrroloiminoquinone alkaloid compounds indicated modulation of Hsp90 and Hsp90 partner proteins by the compounds. Naphthoquinone compounds were prioritised for analysis for binding to Hsp90β over the pyrroloiminoquinone alkaloid compounds. Lapachol interacted with Hsp90β with a low affinity however; this interaction was thought to be too weak to disrupt the association of Hsp90 and Hop. The remaining naphthoquinone compounds showed no interaction with Hsp90β, thus allowing the determination of a preliminary structure-activity relationship for these compounds. To the best of our knowledge, this is the first study to describe a systematic subcellular analysis of the effects of geldanamycin and novobiocin in comparison to sargaquinoic acid and compounds of the naphthoquinone and pyrroloquinoline scaffold on Hsp90 and its partner proteins. / Microsoft� Word 2010 / Adobe Acrobat 9.54 Paper Capture Plug-in

Human African Trypanosomiasis (HAT) is an infectious, vector-borne protozoal disease which is amongst the so-called neglected diseases. In 2000, at a summit of the United Nations, eight Millennium Development Goals (MDGs) were set, to be achieved by 2015. MDG 6 states “to combat HIV/AIDS, malaria & other diseases”. With just under 2 years to go before the end of 2015, HAT is still thriving in developing countries. The drugs currently used for the treatment of HAT are in short supply, have severe side effects and those used to treat late stages of the disease are very difficult to administer. The aforementioned challenges call for research into this neglected disease in order to develop new, safe and easy-to-use medicines. Naphthoquinones are a class of compounds shown to possess anti-parasitic activity, amongst a variety of other biological activities, and therefore this pharmacophore was selected for this study. The purpose of this study was to synthesise derivatives of 2,3-dichloro-1,4- naphthoquinone to be tested for anti-trypanosomal activity and thereafter conduct structureactivity relationship studies. A series of reactions were carried out using thiophenol, phenol and aniline nucleophiles to synthesise thioether (-S-), ether (-O-) and amino (-NH-) derivatives of 2,3-dichloro-1,4-naphthoquinone with various halogen or methyl substituents. Purification of the products was carried out by recrystallisation. Nuclear magnetic resonance (NMR), infra-red (IR) and high pressure liquid chromatography coupled to an electro-spray ionisation mass spectrometer (HPLC-ESI-MS) were the analytical methods used for structural confirmation of the products. There were eighteen 1,4-naphthoquinone derivatives that were successfully synthesised using ethanolic solutions. Unfortunately, attempts to synthesise 1,4-naphthoquinones in reactions involving 2-(trifluoro-methyl)aniline and 2-isopropyl-5-methylphenol were unsuccessful, presumably due to steric hindrance by the bulky ortho-substituents. Although the aims of the synthetic procedures were to obtain both mono- and disubstituted products by nucleophilic displacement of the chlorine atom(s) of 2,3-dichloro-1,4- naphthoquinone, only monosubstituted products were obtained from substitution with aniline and phenol nucleophiles. Thiol nucleophiles, however, selectively yielded disubstituted products only. Synthesised naphthoquinone derivatives were tested against Trypanosoma brucei and calculation of the EC₅₀ values from the obtained dose-response curves was carried out using the four parametric equation. All the 1,4-naphthoquinones showed a degree of potency, except compounds 1b, 3c and 3e, which had little or lack of potency. Structure-activity relationship studies (SARs and QSARs) were carried out to determine which structural features or functional group substituents of the naphthoquinone derivatives contribute or take away from the desired anti-trypanosomal activity. It was found that compounds with the best in vitro anti-trypanosomal potencies in the series of analogous 1,4-naphthoquinone derivatives had EC₅₀ values in the range 2.137 to 2.884 μM. The most potent compound in the series was 2-chloro-3-(4-(trifluoromethyl)phenylamino)-1,4- naphthoquinone 1e; but it was 142-fold less potent than the reference standard of melarsoprol.

This thesis examined the antimicrobial activity of select neotropical plants from Costa Rica and traditional Q’eqchi Maya medicines from Belize. In particular the potential for interference with bacterial quorum sensing (QS) and biofilm formation as well as fungal growth were assessed. Of one hundred and twenty six extracts collected from Costa Rica, one third showed significant QS inhibition while 13 species displayed more biofilm inhibitory activities than the positive control allicin. The active species belonged to the Lepidobotryaceae, Melastomataceae, Meliaceae, Sapindaceae, and Simaroubaceae. Twelve Marcgraviaceae species were tested for the same biological activities; of these, three showed similar QS inhibition to that of the positive control Delisea pulchra (Greville) Montagne and five with at least 30% biofilm inhibition. Only one species inhibited fungal growth – Marcgravia nervosa Triana & Planch. Bioassay-guided isolation of this plant resulted in the identification of the active principle as a naphthoquinone, with a minimum inhibitory concentration (MIC) ranging from 85 to 100 μM against Saccharomyces cerevisiae. Similarly, sixty one Q’eqchi’ Maya medicinal plant species were evaluated for their antimicrobial activities. Of these, four species showed more QS inhibition than D. pulchra, seven with comparable biofilm inhibitory activities that of allicin, and two with similarly antifungal activity to berberine. Two spirostanol saponins were isolated from Cestrum schlechtendahlii G.Don, an active antifungal plant. The major saponin showed growth inhibition against Saccharomyces cerevisiae and Fusarium graminearum, with MICs of 16.5 μM and 132 μM, respectively. Further analyses of this compound using chemical genomics suggested that its antifungal mechanism of action is pleiotropic, affecting multiple targets. Taken together, these findings showed that neotropical plants and traditional Q’eqchi’ Maya medicines contain phytochemicals that interfere with bacterial biofilm formation and quorum sensing as well as fungal growth.

Various anticancer and antibacterial agents have been synthesized via azide chemistry by taking advantage of carbohydrate. Starting from the synthesis of 14 glycosyl azides, a library of carbohydrate-oxazolidinone conjugates and a library of carbohydrate-cyclopamine conjugates with biological interests were synthesized based on a highly efficient "click reaction" assisted by sonication. Some of the conjugates have improved solubility and enhanced anticancer activity. A library of neomycin B derivatives with various modifications at the 5" position has been synthesized. Two leads exhibit prominent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Antibacterial activities were measured when combined with other clinically used antibiotics and significant synergistic activities were observed. Three different classes of aryl N-glycosides have been synthesized by employing 1,4-naphthoquinone and glycosyl azides undergoing a [2+3] cycloaddition. Alkyl azides can also undergo the same cycloaddition. After the removal of the protecting group, a library of 9,10-anthraquinone derivatives with potential anticancer activity and a library of 2-aminomethylene-1,3-indanediones with novel antibacterial activity have been developed, respectively. A one-pot three-component [2+3] cycloaddition for the synthesis of 1-alkyl 1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione and 2-alkyl 2H-naphtho[2,3-d][1,2,3] triazole-4,9-dione has been developed. By taking the advantage of their difference in basicity, both products can be obtained in good purity. Using an allylic azide rearrangement, a convenient method has been developed for the synthesis of several 2',3'-dideoxyaminoglycosides. The antibacterial activity of these novel aminoglycosides also confirms the indispensable role of the 2'-NH2 group for both neomycin and kanamycin classes of aminoglycosides. A novel structural motif containing the hexylaminocarbonyl groups at O-5 and/or O-6 of 2',3'-dideoxyneamine could lead to the production of new aminoglycosides against resistant bacteria.

Yes / We have used literature values for the solubility of vitamin K3 in organic solvents to obtain Abraham descriptorsfor vitamin K3. Although these descriptors themselves are not exceptional in any way, when combined withequations that we have already set out, they lead to the prediction of important properties of vitamin K3.These include the vapor pressure and heat of sublimation (necessary for the analysis of data on the concentrationof vitamin K3 in ambient air), and the partitions air-water, air-blood, air-lung, air-fat, air-skin, water-lipid, water-membrane, water-skin, as well as permeation from water through skin. Values of the partitions into biologicalphases are all quite large by comparison to those for organic compounds in general.

No description available.

As part of an International Cooperative Biodiversity Group (ICBG) program and a continuing search for antiproliferative natural products from the Madagascar rainforest, and a collaborative research project established between Virginia Tech and the Institute for Hepatitis and Virus Research (IHVR) focusing on searching for bioactive natural products from tropical forests in South Africa, 20 extracts were selected for investigation based on their antiproliferative activities against A2780 human ovarian cancer cell line or antimalarial activities against the Dd2 strain of Plasmodium falciparum. Bioassay-guided fractionation of seven of the extracts yielded twenty new compounds and twenty-four known compounds, and their structures were elucidated by using a combination of 1D (1H and 13C) and 2D NMR spectroscopy including COSY, HASQC, HMQC, HMBC, and NOESY sequences, mass spectrometry, UV, IR, ECD, optical rotation, and chemical conversions. In addition, ten known compounds were isolated from another five of the extracts, while studies on the remaining extracts were suspended due to loss of activity, unworkable small amounts of material, or low structural interest. The plants and their metabolites are discussed in the following order: five new antimalarial 5,6-dihydro-𝛼-pyrones and six bicyclic tetrahydro-𝛼-pyrone derivatives from Cryptocarya rigidifolia (Lauraceae); two new and five known antiproliferative lignans from Cleistanthus boivinianus (Phyllanthaceae); two new and two known antiproliferative sesquiterpenes lactones from Piptocoma antillana (Asteraceae); one new antiproliferative 1,4-naphthoquinone, one known antiproliferative isoflovonoid, and five known antiproliferative stilbenoids from Stuhlmannia moavi (Leguminosae); four known antiproliferative bisbenzylisoquinoline alkaloids from Anisocycla grandidieri (Menispermaceae); one new and two known antiproliferative butanolides, and two new antiproliferative secobutanolides from Ocotea macrocarpa (Lauraceae); one new antiproliferative and five known antiproliferative diterpenoids from Malleastrum rakotozafyi (Meliceae); and 10 known compounds from Monoporus sp. (Myrsinaceae), Premna corymbosa (Verbenaceae), Premna perplexanes (Verbenaceae), Epallage longipes (Asteraceae), and Cinnamosma fragrans (Canellaceae). / Ph. D.

Submitted by (lucia.rodrigues@ufrpe.br) on 2017-02-15T13:39:52Z No. of bitstreams: 1 Mauro Gomes da Silva.pdf: 2235103 bytes, checksum: 2f7922e62d0e9e6cd2bbc309f61aa8f1 (MD5) / Made available in DSpace on 2017-02-15T13:39:52Z (GMT). No. of bitstreams: 1 Mauro Gomes da Silva.pdf: 2235103 bytes, checksum: 2f7922e62d0e9e6cd2bbc309f61aa8f1 (MD5) Previous issue date: 2012-03-14 / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / In the present study ten 2,3-diyne-1,4-naphthoquinone derivatives were synthesized by Sonogashira coupling reaction between the 2,3-dibromo-1,4- naphthoquinone and several functionalized terminal alkynes using a catalytic complex of palladium (II) and CuI. Alkynes are among phenylacetylene, 1-ethyl-4- methoxybenzene, 2-methyl-3-butyn-2-ol, 1-ethynyl-1-cyclohexanol, 4-pentyn-2-ol, 4- pentyn-1-ol, 1-pentyne, 1-hexyne, 1-octyne and 1-decyne. The yields of products obtained ranged 15 to 55%. The enediynes having hydroxyl groups, in their structures such as 2,3-di(3-hydroxy-3-methylbut-1-yn-1-yl)-, 2,3-di[(1- hydroxycyclohexyl)ethynyl]- and 2,3-di(5-hydroxypent-1-yl)-1,4-naphthoquinone were subjected to acetylation reaction using acetic anhydride and montmorillonite clay K- 10 under sonication, thereby obtaining three new enediyne derivatives with yields ranging from 56 to 71%. The compounds were all characterized by 1H NMR and 13C NMR spectra, IR and MS-LC. These compounds containing the 1,4-naphthoquinone nucleus and acetylenic substituents in the quinonoid ring form a enediyne system (Z-3-ene-1,5-diyne) highly reactive, possibly subject to Bergman cycloaromatization, with potential antitumor activity. The enediynes underwent evaluation of the cytotoxic potential against three tumor cell lines, OVCAR-8 (ovarian adenocarcinoma - human), PC-3M (metastatic prostate cancer - human), NCI-H358M (bronchoalveolar lung carcinoma - human), presenting, in general, satisfactory results for inhibition of cell growth. The compound 2,3-di(3-hydroxy-3-methylbut-1-yn-yl)-1,4-naphthoquinone where said among the substances analyzed by presenting a lower IC50 (˂ 2 μg/mL) for three cell lines tested, which is characterized as a potent cytotoxic agent. / No presente trabalho foram obtidos dez derivados 2,3-diino-1,4- naftoquinonas, entre estes sete são inéditos na literatura, empregando a reação de acoplamento de Sonogashira entre o 2,3-dibromo-1,4-naftoquinona e diversos alquinos terminais funcionalizados, utilizando um complexo catalítico de paládio (II) e CuI. Entre os alquinos estão o fenilacetileno, o 4-metoxifenilacetileno, o 2-metil-3- butin-2-ol, o 1-etinil-1-cicloexanol, o 4-pentin-2-ol, o 4-pentin-1-ol, o 1-pentino, o 1- hexino, o 1-octino e o 1-decino. Os rendimentos dos produtos obtidos variaram entre 15-55%. Os enediinos que possuem grupos hidroxilas presentes em suas estruturas, como o 2,3-di(3-hidroxi-3-metilbut-1-in-il)-, o 2,3-di[(1-hidroxicicloexil)etinil]- e o 2,3- di(5-hidroxipent-1-il)-1,4-naftoquinona, foram submetidos à reação de acetilação utilizando anidrido acético e argila montmorillonita K-10 em ultrassom, obtendo assim, três novos derivados enediinos com rendimentos que variaram de 56-71%. Os compostos obtidos foram todos caracterizados por espectros de RMN 1H e RMN 13C, LC-MS e IV. Estes compostos contendo o núcleo 1,4-naftoquinona e substituintes acetilênicos no anel quinônico formam um sistema enediino (Z-3-eno-1,5-diino) altamente reativo, possivelmente sujeito a cicloaromatização de Bergman, com potencial atividade antitumoral. Os enediinos foram submetidos à avaliação do potencial citotóxico em três linhagens de células tumorais, OVCAR-8 (adenocarcinoma de ovário – humano), PC-3M (carcinoma de próstata metastático – humano), NCI-H358M (carcinoma bronquioalveolar de pulmão – humano, apresentando, no geral, resultados satisfatórios para inibição do crescimento celular. O composto 2,3-di(3-hidroxi-3-metilbut-1-in-1-il)-1,4-naftoquinona se destacou dentre as substâncias analisadas por apresentar menor CI50 (˂ 2 μg/mL) para as três linhagens de células testadas, o que o caracteriza como potente agente citotóxico.